Standard and Poor’s Revises Ballad Health Outlook to “Positive,” Affirming “A-” RatingDespite industry-wide pressures leading to credit downgrades outpacing upgrades, S&P’s positive revision cites Ballad Health’s experienced management team, execution of integration strategy, and quality improvement serving to “transform Ballad Health into a high-performing consolidated system”
Despite “industry challenges,” national rating agencies maintain Ballad Health “A” ratings with “stable” outlookEfforts to stabilize workforce due to national labor shortages, provide improved quality and performance and maintain access highlighted in reports
Ballad Health, Niswonger Foundation Make Lifesaving Investment to Enhance Availability of Kidneys for Transplant, Reduce Costs of CareNew procedure gives hope to thousands of people awaiting transplant, supports Ballad Health’s goal of saving 100,000 years of life over the next decade while reducing cost for individuals, employers and taxpayers
National Study: Ballad Health, ETSU Trauma Consolidation Saves Hundreds of LivesStudy shows “significantly decreased” death rates and decreased transfers to other facilities from the most serious traumatic injuries since consolidation of Level 1 trauma centers in the Appalachian Highlands
Ballad Health partners with 410 Medical for rapid fluid deliveryJOHNSON CITY, Tenn., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Ballad Health and the Ballad Health Innovation Center are partnering with 410 Medical, Inc. to use its LifeFlow device, a rapid fluid delivery mechanism that reduces the time needed to revive a patient in need of blood or fluids.
Ballad Health partners with MedAware to leverage artificial intelligence platform to improve patient safety and optimize pharmacy workflowsJOHNSON CITY, Tenn., June 28, 2023 (GLOBE NEWSWIRE) -- Ballad Health is partnering with Israeli-based MedAware, Ltd., to leverage artificial intelligence (AI) to improve patient safety by identifying potential medication-related errors and improving operational efficiency within the pharmacy.
National Rating Agencies Cite Quality, Cost Efficiency, Access and Performance in Affirming Ballad Health Credit RatingsDespite the ongoing negative outlook for the hospital industry, and against an avalanche of downgrades nationwide, Fitch Ratings, Moody’s and S&P Global Ratings have affirmed Ballad Health’s “A” ratings, citing improved quality, lower healthcare costs
Ballad Ventures selects two experienced health system leaders as key advisorsJOHNSON CITY, Tenn., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Ballad Ventures, a healthcare venture capital subsidiary of Ballad Health, has selected Amit Vashist, MD, and Pam Austin as key advisors. Dr. Vashist serves as Ballad Health's chief clinical officer, and Austin is the health system's chief information officer.
